Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.9%

2 terminated/withdrawn out of 106 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

13%

14 trials in Phase 3/4

Results Transparency

7%

1 of 14 completed trials have results

Key Signals

31 recruiting1 with results

Enrollment Performance

Analytics

N/A
32(47.1%)
Phase 2
16(23.5%)
Phase 3
8(11.8%)
Phase 4
6(8.8%)
Phase 1
3(4.4%)
Early Phase 1
3(4.4%)
68Total
N/A(32)
Phase 2(16)
Phase 3(8)
Phase 4(6)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (106)

Showing 20 of 106 trials
NCT07518693Completed

Clinical Observation of Hysteroscopy-Assisted Placement of Handmade Frameless GyneFix-LNG-IUS (Retrospective Cohort)

Role: collaborator

NCT03785574Not ApplicableRecruiting

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

Role: lead

NCT07445880Not ApplicableCompleted

Clinical Application and Efficacy of a Self-Locking Uterine Manipulator Stand in Hysterectomy

Role: lead

NCT07082530Not ApplicableRecruiting

A RCT of Labor Induction at 39 Weeks in Low - Risk Women in China

Role: lead

NCT07369986Phase 2Not Yet Recruiting

Immunotherapy for Surgery Avoidance in Vulnerable dMMR Endometrial Cancer

Role: lead

NCT07365254Recruiting

Accurate Assessment and Intervention Research on Newborn Whole Genome Sequencing and Genetic Disease Risk

Role: lead

NCT06334783Phase 1Terminated

TIL for Patients With Advanced Solid Tumor

Role: collaborator

NCT06832800Early Phase 1Recruiting

Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH

Role: lead

NCT05776082Recruiting

Association of Gestational Cardiovascular Health With Pregnancy Outcomes

Role: lead

NCT07306247Not ApplicableNot Yet Recruiting

Multicenter Prospective Non-randomized Controlled Study of ALA-PDT for LSIL With HPV16/18 Infection

Role: collaborator

NCT07306260Not ApplicableNot Yet Recruiting

Multicenter Prospective Non-randomized Controlled Study of Ella Photodynamic Therapy for Cervical HSIL/CIN2

Role: collaborator

NCT07167160Phase 2Recruiting

Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial

Role: lead

NCT06866951Phase 2Withdrawn

A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial

Role: lead

NCT06285604Active Not Recruiting

Effect Evaluation of Different Blood Products Infusion on Neonatal Anemia

Role: lead

NCT06561308Phase 2Recruiting

Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

Role: lead

NCT07244965Phase 2Not Yet Recruiting

Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer

Role: lead

NCT07240753Not Yet Recruiting

A Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma

Role: collaborator

NCT03736707Not ApplicableRecruiting

High-Frequency Oscillation Ventilation Versus Conventional Mechanical Ventilation in Very Preterm Infants With Perinatal Acute Respiratory Distress Syndrome: Multicenters Randomized Controlled, Superiority Trial

Role: collaborator

NCT04555226Not ApplicableRecruiting

The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)

Role: collaborator

NCT06546397Phase 1Recruiting

Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion

Role: lead